Birdwatch Note
2024-04-29 22:30:04 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Los coágulos de sangre son un efecto secundario extremadamente raro de la vacuna Astra Zeneca, se informó por primera vez en 2021, cuando comenzó la campaña de vacunación. - Astra Zeneca acaba de repetirlo ante el tribunal y se tergiversa como una confesión forzada. https://www.nytimes.com/2021/04/10/health/astrazeneca-vaccine-blood-clots.html
Written by 42BE37D76A013DC81FF84C5EB39204002B9D9DDAABE495E5E928B10D5C97C930
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1785022788681585080
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1785074098369872206
- noteId - 1785074098369872206
- participantId -
- noteAuthorParticipantId - 42BE37D76A013DC81FF84C5EB39204002B9D9DDAABE495E5E928B10D5C97C930 Participant Details
- createdAtMillis - 1714429804782
- tweetId - 1785022788681585080
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Los coágulos de sangre son un efecto secundario extremadamente raro de la vacuna Astra Zeneca, se informó por primera vez en 2021, cuando comenzó la campaña de vacunación. - Astra Zeneca acaba de repetirlo ante el tribunal y se tergiversa como una confesión forzada. https://www.nytimes.com/2021/04/10/health/astrazeneca-vaccine-blood-clots.html
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-04-29 22:30:04 UTC (1714429804782) |
2024-04-30 02:10:09 UTC (1714443009054) |
CURRENTLY_RATED_HELPFUL | 2024-05-01 12:35:12 UTC (1714566912495) |
CURRENTLY_RATED_HELPFUL | 2024-04-30 02:10:09 UTC (1714443009054) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-04-30 19:30:16 -0500 | Rating Details | |
2024-04-30 17:56:55 -0500 | Rating Details | |
2024-04-30 16:11:22 -0500 | Rating Details | |
2024-04-30 15:58:35 -0500 | Rating Details | |
2024-04-30 15:08:51 -0500 | Rating Details | |
2024-04-30 14:29:58 -0500 | Rating Details | |
2024-04-30 13:06:06 -0500 | Rating Details | |
2024-04-30 12:57:52 -0500 | Rating Details | |
2024-04-30 12:19:41 -0500 | Rating Details | |
2024-04-30 10:29:33 -0500 | Rating Details | |
2024-04-30 09:29:34 -0500 | Rating Details | |
2024-04-30 09:27:41 -0500 | Rating Details | |
2024-04-30 08:20:14 -0500 | Rating Details | |
2024-04-30 07:40:09 -0500 | Rating Details | |
2024-04-30 07:27:33 -0500 | Rating Details | |
2024-04-30 06:58:18 -0500 | Rating Details | |
2024-04-30 00:37:41 -0500 | Rating Details | |
2024-04-30 00:22:27 -0500 | Rating Details | |
2024-04-29 23:56:52 -0500 | Rating Details | |
2024-04-29 23:56:41 -0500 | Rating Details | |
2024-04-29 23:23:12 -0500 | Rating Details | |
2024-04-29 23:14:34 -0500 | Rating Details | |
2024-04-29 22:50:43 -0500 | Rating Details | |
2024-04-29 22:46:06 -0500 | Rating Details | |
2024-04-29 22:31:33 -0500 | Rating Details | |
2024-04-29 22:26:38 -0500 | Rating Details | |
2024-04-29 22:22:29 -0500 | Rating Details | |
2024-04-29 22:08:07 -0500 | Rating Details | |
2024-04-29 21:52:39 -0500 | Rating Details | |
2024-04-29 21:44:44 -0500 | Rating Details | |
2024-04-29 21:11:59 -0500 | Rating Details | |
2024-04-29 21:02:07 -0500 | Rating Details | |
2024-04-29 20:28:09 -0500 | Rating Details | |
2024-04-29 20:27:12 -0500 | Rating Details | |
2024-04-29 20:03:16 -0500 | Rating Details | |
2024-04-29 20:01:00 -0500 | Rating Details | |
2024-04-29 19:17:42 -0500 | Rating Details | |
2024-04-29 19:08:05 -0500 | Rating Details | |
2024-04-29 17:47:16 -0500 | Rating Details | |
2024-05-01 12:07:01 -0500 | Rating Details | |
2024-05-01 00:11:46 -0500 | Rating Details | |
2024-04-30 21:36:14 -0500 | Rating Details | |
2024-04-30 21:24:45 -0500 | Rating Details | |
2024-04-30 20:30:15 -0500 | Rating Details | |
2024-04-30 21:57:02 -0500 | Rating Details | |
2024-04-30 21:15:21 -0500 | Rating Details | |
2024-04-30 16:49:42 -0500 | Rating Details | |
2024-04-30 12:22:34 -0500 | Rating Details | |
2024-04-30 10:41:35 -0500 | Rating Details | |
2024-04-30 09:26:27 -0500 | Rating Details | |
2024-04-30 08:23:26 -0500 | Rating Details | |
2024-04-30 06:01:23 -0500 | Rating Details | |
2024-04-30 03:18:57 -0500 | Rating Details | |
2024-04-30 01:34:32 -0500 | Rating Details | |
2024-04-30 01:01:54 -0500 | Rating Details | |
2024-04-30 00:26:24 -0500 | Rating Details | |
2024-04-30 00:13:00 -0500 | Rating Details | |
2024-04-29 23:43:07 -0500 | Rating Details | |
2024-04-29 23:14:20 -0500 | Rating Details | |
2024-04-29 23:00:39 -0500 | Rating Details | |
2024-04-29 22:51:12 -0500 | Rating Details | |
2024-04-29 22:32:35 -0500 | Rating Details | |
2024-04-29 22:06:38 -0500 | Rating Details | |
2024-04-29 21:55:27 -0500 | Rating Details | |
2024-04-29 21:51:29 -0500 | Rating Details | |
2024-04-29 21:33:32 -0500 | Rating Details | |
2024-04-29 21:26:16 -0500 | Rating Details | |
2024-04-29 21:06:35 -0500 | Rating Details | |
2024-04-29 20:57:48 -0500 | Rating Details | |
2024-04-29 20:33:30 -0500 | Rating Details | |
2024-04-29 19:52:04 -0500 | Rating Details | |
2024-04-29 19:45:50 -0500 | Rating Details | |
2024-04-29 19:41:31 -0500 | Rating Details | |
2024-04-29 19:28:54 -0500 | Rating Details | |
2024-04-29 18:15:17 -0500 | Rating Details | |
2024-04-29 17:54:21 -0500 | Rating Details | |
2024-05-01 08:50:48 -0500 | Rating Details | |
2024-05-01 01:59:50 -0500 | Rating Details | |
2024-04-30 22:09:46 -0500 | Rating Details | |
2024-04-30 19:01:03 -0500 | Rating Details | |
2024-04-30 17:12:08 -0500 | Rating Details | |
2024-04-30 15:53:45 -0500 | Rating Details | |
2024-04-30 15:30:23 -0500 | Rating Details | |
2024-04-30 14:23:35 -0500 | Rating Details | |
2024-04-30 12:24:19 -0500 | Rating Details | |
2024-04-30 10:37:31 -0500 | Rating Details | |
2024-04-30 08:11:47 -0500 | Rating Details | |
2024-04-30 08:00:55 -0500 | Rating Details | |
2024-04-30 08:00:17 -0500 | Rating Details | |
2024-04-30 07:32:52 -0500 | Rating Details | |
2024-04-30 06:45:48 -0500 | Rating Details | |
2024-04-30 04:42:59 -0500 | Rating Details | |
2024-04-30 01:59:01 -0500 | Rating Details | |
2024-04-30 00:31:38 -0500 | Rating Details | |
2024-04-30 00:17:23 -0500 | Rating Details | |
2024-04-29 23:38:55 -0500 | Rating Details | |
2024-04-29 23:15:36 -0500 | Rating Details | |
2024-04-29 22:52:34 -0500 | Rating Details | |
2024-04-29 22:28:03 -0500 | Rating Details | |
2024-04-29 22:27:11 -0500 | Rating Details | |
2024-04-29 21:41:45 -0500 | Rating Details | |
2024-04-29 21:36:27 -0500 | Rating Details | |
2024-04-29 21:25:59 -0500 | Rating Details | |
2024-04-29 21:14:31 -0500 | Rating Details | |
2024-04-29 20:45:07 -0500 | Rating Details | |
2024-04-29 20:35:32 -0500 | Rating Details | |
2024-04-29 19:26:57 -0500 | Rating Details | |
2024-04-29 19:18:14 -0500 | Rating Details | |
2024-04-29 19:06:34 -0500 | Rating Details | |
2024-04-29 18:48:06 -0500 | Rating Details | |
2024-04-29 18:40:42 -0500 | Rating Details | |
2024-04-29 18:38:21 -0500 | Rating Details | |
2024-04-29 18:05:49 -0500 | Rating Details | |
2024-04-29 17:33:55 -0500 | Rating Details | |
2024-05-01 21:30:35 -0500 | Rating Details | |
2024-05-04 12:28:29 -0500 | Rating Details | |
2024-05-01 11:20:03 -0500 | Rating Details | |
2024-05-01 05:25:06 -0500 | Rating Details | |
2024-04-30 23:30:24 -0500 | Rating Details | |
2024-04-30 23:11:21 -0500 | Rating Details | |
2024-04-30 20:19:14 -0500 | Rating Details | |
2024-04-30 16:00:24 -0500 | Rating Details | |
2024-04-30 14:21:55 -0500 | Rating Details | |
2024-04-30 13:13:06 -0500 | Rating Details | |
2024-04-30 12:18:20 -0500 | Rating Details | |
2024-04-30 11:53:30 -0500 | Rating Details | |
2024-04-30 11:25:32 -0500 | Rating Details | |
2024-04-30 10:00:02 -0500 | Rating Details | |
2024-04-30 09:35:32 -0500 | Rating Details | |
2024-04-30 08:34:31 -0500 | Rating Details | |
2024-04-30 07:43:46 -0500 | Rating Details | |
2024-04-30 05:05:29 -0500 | Rating Details | |
2024-04-30 01:51:11 -0500 | Rating Details | |
2024-04-30 01:01:02 -0500 | Rating Details | |
2024-04-30 00:52:49 -0500 | Rating Details | |
2024-04-30 00:03:18 -0500 | Rating Details | |
2024-04-29 22:40:50 -0500 | Rating Details | |
2024-04-29 22:33:44 -0500 | Rating Details | |
2024-04-29 22:12:36 -0500 | Rating Details | |
2024-04-29 22:09:32 -0500 | Rating Details | |
2024-04-29 21:42:44 -0500 | Rating Details | |
2024-04-29 20:51:46 -0500 | Rating Details | |
2024-04-29 20:22:33 -0500 | Rating Details | |
2024-04-29 19:15:38 -0500 | Rating Details | |
2024-04-29 19:13:56 -0500 | Rating Details | |
2024-04-29 19:11:48 -0500 | Rating Details | |
2024-04-29 19:06:40 -0500 | Rating Details | |
2024-04-29 17:43:30 -0500 | Rating Details | |
2024-04-30 04:25:35 -0500 | Rating Details |